Services
Have us run the campaign
The studio is there for teams who want to drive. When you would rather hand over the target and get back ranked, testable candidates, our team takes the project end to end.
How an engagement works
- Scoping callThirty minutes on your target, what you have already tried, and what a successful candidate has to do. We tell you honestly whether computational design is the right tool for it.
- Target triage and preparationStructure selection, domain trimming, epitope and hotspot definition. Most campaigns that fail, fail here rather than in the model.
- Design campaignWe run the pipelines best suited to the target — usually several in parallel — and iterate on the ones that show signal instead of scaling the first attempt.
- Ranked deliveryYou get candidate sequences and structures, ranked with the metrics behind the ranking, plus what we would order and test first.
- Wet-lab handoffExpression and characterization guidance, and a feedback loop from your results back into the next design round.
Campaigns we have run
De novo CAR-T binders
Custom binders for chimeric antigen receptor therapy.
Transcription factor inhibitors
Targeting classically undruggable transcription factors.
De novo neoantigen binders
Personalized cancer neoantigen targeting.
Peptide inhibitors
Constrained peptides for tough targets.
De novo antibodies
Fully synthetic antibody scaffolds.
CDR optimization
Affinity maturation via CDR redesign.
De novo antivirals
Broad-spectrum antiviral binders.
Also available
- Consulting and integration — standing up protein design inside your own stack, including the public API and automated submission pipelines.
- Method selection review — a read on which tools and settings suit your target class, if you want to run it yourself but not from scratch.
- Results review — a second opinion on a campaign you have already run, before you spend money at the bench.
Start a conversation
Project pricing depends on target difficulty and scope, so it is quoted after the scoping call rather than listed here.